form_8k-011002
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report: January 10, 2002
Medix Resources, Inc.
(Exact name of registrant as specified in its charter)
Colorado 0-24768 84-1123311
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
305 Madison Avenue, Suite 2033, New York, NY 10165
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (212) 697-2509
Item 5. Other Events. Press release announcing Medix to present at UBS Warburg's Global
Healthcare Services Conference.
Exhibits:
Exhibit 99.1 - Copy of Press Release
Information herein contains forward-looking statements that involve risks and
uncertainties that might adversely affect the Company's operating results in the
future to a material degree. Such risks and uncertainties include, without
limitation, the ability of the Company to raise capital to finance the
development of its software products, the effectiveness and the marketability of
those products, the ability of the Company to protect its proprietary
information, and the establishment of an efficient corporate operating structure
as the Company grows. These and other risks and uncertainties are presented in
detail in the Company's Form 10-KSB for 2000,and its Form 10-Q for the third
quarter of 2001, which were filed with the Securities and Exchange Commission.
This information is available from the SEC or the Company.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDIX RESOURCES, INC.
Date: January 10, 2002 By: Gary L. Smith
Executive Vice President and
Chief Financial Officer
Exhibit 99.1
[GRAPHIC OMITTED][GRAPHIC OMITTED]
News Release
CONTACT: Gary Smith
(212) 697-2509
(212) 681-9817 (fax)
Andy Brown
(718) 323-7424
MEDIX RESOURCES TO PRESENT AT UBS WARBURG'S GLOBAL HEALTHCARE SERVICES CONFERENCE
------
New York, January 10, 2002 - Medix Resources (AMEX: MXR) today announced that it
be presenting at UBS Warburg's Global Healthcare Services Conference. The conference, to be
held at The Plaza Hotel in New York City, will be held from Monday, February 4 through
Thursday, February 7, 2002.
John R. Prufeta, President and Chief Executive Officer of Medix Resources, will be
presenting on Thursday, February 7 from 11:00 - 11:30 a.m., immediately followed by a
20-minute Q & A session.
"The UBS Warburg Global Healthcare Services Conference is an annual high point for
organizations in the healthcare sector. Medix Resources is delighted to have the
opportunity to present at this quality event," commented Mr. Prufeta.
About Medix Resources, Inc.
Medix Resources, Inc., through its wholly owned subsidiary Cymedix Lynx Corporation,
is the developer and provider of the Cymedix(R)suite of fully secure, Internet based
transaction software products, that enable communication of high value added healthcare
information among physician offices, hospitals, health management organizations and
insurance companies. Additional information about Medix Resources and its products and
services can be found by visiting its Web sites, WWW.MEDIXRESOURCES.COM and
www.cymedix.com, or by calling (800) 326-8773.
# # #
Information in this press release contains forward-looking statements that involve risks
and uncertainties that might adversely affect the Company's operating results in the future
to a material degree. Such risks and uncertainties include, without limitation, the ability
of the Company to raise capital to finance the development of its software products, the
effectiveness and the marketability of those products, the ability of the Company to
protect its proprietary information, and the establishment of an efficient corporate
operating structure as the Company grows. These and other risks and uncertainties are
presented in detail in the Company's Form 10-KSB for 2000, and its Form 10-Q for the third
quarter of 2001, which were filed with the Securities and Exchange Commission on March 21,
2001, and November 14, 2001, respectively. This information is available from the SEC or
the Company.